Steps forward for cancer precision medicine

Nature Reviews Drug Discovery 17, 1 (2018). doi:10.1038/nrd.2017.218 Authors: Roberto Salgado, Helen Moore, John W. M. Martens, Tracy Lively, Shakun Malik, Ultan McDermott, Stefan Michiels, Jeffrey A. Moscow, Sabine Tejpar, Tawnya McKee & Denis Lacombe The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Comment Source Type: research